预测肺腺癌淋巴管侵犯的提名图:一项回顾性研究。

IF 2.6 3区 医学 Q2 RESPIRATORY SYSTEM BMC Pulmonary Medicine Pub Date : 2024-11-28 DOI:10.1186/s12890-024-03400-3
Miaomaio Lin, Xiang Zhao, Haipeng Huang, Huashan Lin, Kai Li
{"title":"预测肺腺癌淋巴管侵犯的提名图:一项回顾性研究。","authors":"Miaomaio Lin, Xiang Zhao, Haipeng Huang, Huashan Lin, Kai Li","doi":"10.1186/s12890-024-03400-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Backgroud: </strong>Lymphovascular invasion (LVI) was histological factor that was closely related to prognosis of lung adenocarcinoma (LAC).The primary aim was to investigate the value of a nomogram incorporating clinical and computed tomography (CT) factors to predict LVI in LAC, and validating the predictive efficacy of a clinical model for LVI in patients with lung adenocarcinoma with lesions ≤ 3 cm.</p><p><strong>Methods: </strong>A total of 450 patients with LAC were retrospectively enrolled. Clinical data and CT features were analyzed to identify independent predictors of LVI. A nomogram incorporating the independent predictors of LVI was built. The performance of the nomogram was evaluated by assessing its discriminative ability and clinical utility.We took 321 patients with tumours ≤ 3 cm in diameter to continue constructing the clinical prediction model, which was labelled subgroup clinical model.</p><p><strong>Results: </strong>Carcinoembryonic antigen (CEA) level, maximum tumor diameter, spiculation, and vacuole sign were independent predictors of LVI. The LVI prediction nomogram showed good discrimination in the training set [area under the curve (AUC), 0.800] and the test set (AUC, 0.790), the subgroup clinical model also owned the stable predictive efficacy for preoperative prediction of LVI in lung adenocarcinoma patients, and both training and test set AUC reached 0.740.</p><p><strong>Conclusions: </strong>The nomogram developed in this study could predict the risk of LVI in LAC patients, facilitate individualized risk-stratification, and help inform treatment decision-makin, and the subgroup clinical model also had good predictive performance for lung cancer patients with lesion ≤ 3 cm in diameter.</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"24 1","pages":"588"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11603933/pdf/","citationCount":"0","resultStr":"{\"title\":\"A nomogram for predicting lymphovascular invasion in lung adenocarcinoma: a retrospective study.\",\"authors\":\"Miaomaio Lin, Xiang Zhao, Haipeng Huang, Huashan Lin, Kai Li\",\"doi\":\"10.1186/s12890-024-03400-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Backgroud: </strong>Lymphovascular invasion (LVI) was histological factor that was closely related to prognosis of lung adenocarcinoma (LAC).The primary aim was to investigate the value of a nomogram incorporating clinical and computed tomography (CT) factors to predict LVI in LAC, and validating the predictive efficacy of a clinical model for LVI in patients with lung adenocarcinoma with lesions ≤ 3 cm.</p><p><strong>Methods: </strong>A total of 450 patients with LAC were retrospectively enrolled. Clinical data and CT features were analyzed to identify independent predictors of LVI. A nomogram incorporating the independent predictors of LVI was built. The performance of the nomogram was evaluated by assessing its discriminative ability and clinical utility.We took 321 patients with tumours ≤ 3 cm in diameter to continue constructing the clinical prediction model, which was labelled subgroup clinical model.</p><p><strong>Results: </strong>Carcinoembryonic antigen (CEA) level, maximum tumor diameter, spiculation, and vacuole sign were independent predictors of LVI. The LVI prediction nomogram showed good discrimination in the training set [area under the curve (AUC), 0.800] and the test set (AUC, 0.790), the subgroup clinical model also owned the stable predictive efficacy for preoperative prediction of LVI in lung adenocarcinoma patients, and both training and test set AUC reached 0.740.</p><p><strong>Conclusions: </strong>The nomogram developed in this study could predict the risk of LVI in LAC patients, facilitate individualized risk-stratification, and help inform treatment decision-makin, and the subgroup clinical model also had good predictive performance for lung cancer patients with lesion ≤ 3 cm in diameter.</p>\",\"PeriodicalId\":9148,\"journal\":{\"name\":\"BMC Pulmonary Medicine\",\"volume\":\"24 1\",\"pages\":\"588\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-11-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11603933/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMC Pulmonary Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12890-024-03400-3\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pulmonary Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12890-024-03400-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

摘要

背景:淋巴管侵犯(LVI)是与肺腺癌(LAC)预后密切相关的组织学因素。研究的主要目的是探讨结合临床和计算机断层扫描(CT)因素的提名图预测LAC淋巴管侵犯的价值,并验证病灶小于3厘米的肺腺癌患者LVI临床模型的预测效果:方法:共回顾性纳入 450 例 LAC 患者。对临床数据和 CT 特征进行分析,以确定 LVI 的独立预测因素。建立了一个包含 LVI 独立预测因素的提名图。我们选取了 321 例肿瘤直径小于 3 厘米的患者,继续构建临床预测模型,并将其命名为亚组临床模型:结果:癌胚抗原(CEA)水平、肿瘤最大直径、骨刺和空泡征是LVI的独立预测指标。LVI预测提名图在训练集(曲线下面积(AUC)为0.800)和测试集(AUC为0.790)中显示出良好的区分度,亚组临床模型对肺腺癌患者术前预测LVI也具有稳定的预测效果,训练集和测试集的AUC均达到0.740:本研究建立的提名图可以预测肺腺癌患者发生LVI的风险,促进个体化风险分级,并为治疗决策提供参考,亚组临床模型对病灶直径≤3厘米的肺腺癌患者也具有良好的预测效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A nomogram for predicting lymphovascular invasion in lung adenocarcinoma: a retrospective study.

Backgroud: Lymphovascular invasion (LVI) was histological factor that was closely related to prognosis of lung adenocarcinoma (LAC).The primary aim was to investigate the value of a nomogram incorporating clinical and computed tomography (CT) factors to predict LVI in LAC, and validating the predictive efficacy of a clinical model for LVI in patients with lung adenocarcinoma with lesions ≤ 3 cm.

Methods: A total of 450 patients with LAC were retrospectively enrolled. Clinical data and CT features were analyzed to identify independent predictors of LVI. A nomogram incorporating the independent predictors of LVI was built. The performance of the nomogram was evaluated by assessing its discriminative ability and clinical utility.We took 321 patients with tumours ≤ 3 cm in diameter to continue constructing the clinical prediction model, which was labelled subgroup clinical model.

Results: Carcinoembryonic antigen (CEA) level, maximum tumor diameter, spiculation, and vacuole sign were independent predictors of LVI. The LVI prediction nomogram showed good discrimination in the training set [area under the curve (AUC), 0.800] and the test set (AUC, 0.790), the subgroup clinical model also owned the stable predictive efficacy for preoperative prediction of LVI in lung adenocarcinoma patients, and both training and test set AUC reached 0.740.

Conclusions: The nomogram developed in this study could predict the risk of LVI in LAC patients, facilitate individualized risk-stratification, and help inform treatment decision-makin, and the subgroup clinical model also had good predictive performance for lung cancer patients with lesion ≤ 3 cm in diameter.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BMC Pulmonary Medicine
BMC Pulmonary Medicine RESPIRATORY SYSTEM-
CiteScore
4.40
自引率
3.20%
发文量
423
审稿时长
6-12 weeks
期刊介绍: BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
期刊最新文献
Predicting solitary pulmonary lesions in breast cancer patients using 18fluorodeoxyglucose-positron emission tomography/computed tomography combined with clinicopathological characteristics. Assessment of novel cardiovascular biomarkers in chronic obstructive pulmonary disease. Comparison of efficacy and safety of neoadjuvant immunochemotherapy in young and elderly patients with IIA-IIIB non-small-cell lung cancer in real-world practice. Development of a predictive nomogram for early identification of pulmonary embolism in hospitalized patients: a retrospective cohort study. A nomogram for predicting lymphovascular invasion in lung adenocarcinoma: a retrospective study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1